ArticleFrontiers in medicine2022

Regulatory policy and pharmaceutical innovation in the United Kingdom after Brexit: Initial insights.

Matthias P Hofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.